GE HealthCare said total revenues for the quarter ended June 30, 2025 were $5,007 million, growing 3% as reported and 2% organically. Sales of services increased 7%, or $111 million.

1. 01

   GE HealthCare said total revenues for the quarter ended June 30, 2025 were $5,007 million, growing 3% as reported and 2% organically. Sales of services increased 7%, or $111 million.

2. 02

   The company said tariffs materially impacted profitability and cash flows for the quarter ended June 30, 2025. Gross profit for the quarter decreased $17 million, and Adjusted EBIT was $729 million with a margin of 14.6%.

3. 03

   GE HealthCare said cash from operating activities for the first half of 2025 was $344 million, and free cash flow was $106 million. Financing activities included net proceeds from the issuance of senior unsecured notes of $1,487 million and repayment of the Term Loan Facility of $250 million.

4. 04

   The company said total debt as of June 30, 2025 was $10,275 million, an increase from $8,951 million as of December 31, 2024. It plans to repay senior unsecured notes maturing in November 2025 of $1,500 million using net proceeds from new notes and cash on hand.

Key figures

Quarter ended June 30, 2025

Revenue

$5.0B

Operating income

$654M

Net income

$486M

EPS

$1.06

Gross profit

$2.0B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.